My lede:

Highly paid consultants for orthopedic device makers disclose their company ties about half the time and rarely share details with readers about their financial relationships, according to a new study calling for more transparency.

Researchers examined payments from five orthopedic device makers to consultants in 2007 and then zeroed in on the 32 researchers, nearly all physicians, who received more than $1 million each to see whether those relationships were disclosed when they published articles the following year.

When writing directly about the firm’s products, authors paid $1 million or more disclosed their company tie half the time, said the Archives of Internal Medicine study, published online Sept. 13. Only one of the 26 orthopedics-related journals studied, The Journal of Bone and Joint Surgery, required authors to acknowledge they were paid more than $10,000.

Read the whole shebang.

My lede:

The information patients typically use when looking for a new doctor is not very helpful in determining physician quality, according to a new study of more than 10,000 Massachusetts physicians caring for 1.1 million patients.

Researchers found little correlation between physician performance on 124 process-based quality measures in 30 clinical areas and characteristics such as medical education, board certification, malpractice claim payments and disciplinary actions commonly listed by health plans and consumer websites.

Read the whole shebang.

Experts believe patients should be told about mistakes, such as poor infection control, that expose them to potential harm.

Read the whole shebang.

My lede:

In a first-of-its kind bid to make clinical quality performance data available to the public, the Society of Thoracic Surgeons partnered with Consumer Reports in September to rate 221 cardiac surgical groups in 42 states.

The groups are graded on a one- to three-star scale on their performance in providing coronary-artery bypass grafting procedures. The ratings are included in the October issue of the magazine and are available to subscribers at the Consumer Reports website.

The risk-adjusted metrics, developed by the society, gauge patients’ 30-day mortality, complication rates, whether patients receive recommended medications and whether they get at least one optimal surgical graft. The ratings are based on group performance, because grading individual surgeons would be statistically invalid, society leaders said.

Read the whole shebang.

The agency may require suppressants containing dextromethorphan to be stored behind pharmacy counters.

Read the whole shebang.

My lede:

How relationships with industry may influence physician decisions is not just a concern limited to Capitol Hill or medical ethics committees. A new poll found that 69% of patients say they believe drugmakers hold too much sway over doctors’ prescribing.

Nearly half of the 1,154 adults surveyed nationwide said physicians’ prescribing decisions are influenced by gifts from drugmakers, according to poll results released in August. A third of patients were so worried about pharmaceutical marketing that they felt they could not rely on their doctors’ medication advice.

Read the whole shebang.

A study finds that although access to medical care has improved, they remain traumatized by “the perpetual disaster of an unstable future.”

Read the whole shebang.

My lede:

Palliative care not only helps patients with terminal illnesses have less painful deaths but also can increase survival times when it is integrated soon after diagnosis.

That is the finding of a study of 151 Boston-area patients with lung cancer in the Aug. 19 New England Journal of Medicine. The 74 patients who received standard oncologic care at Massachusetts General Hospital for metastatic non-small-cell lung cancer had a median survival time of nine months, compared with nearly a year for the 77 patients who received standard care and visited the hospital’s outpatient palliative care service within three months of diagnosis. The patients getting palliative care lived longer despite spending more time in hospice care and receiving less chemotherapy.

Read the whole shebang.

The storm served as a wake-up call, prompting physicians, hospitals and government officials to re-examine how to best deliver care in catastrophic conditions.

Read the whole shebang.

There is little professional guidance to help physicians navigate connections with patients on Faceboook, Twitter and other sites.

Read the whole shebang.

My lede:

Nurse practitioners and physician assistants account for at least 10% of outpatient visits and increasingly are being used to handle patient care in emergency departments, according to previous research.

But a new survey said 80% of patients expect to see a physician when they come to the ED. Fewer than half would be willing to see an NP or PA for an ankle injury — they would rather wait two more hours to be cared for by a physician.

The whole shebang.

Five years after the hurricane devastated New Orleans’ health system, the city’s medical landscape has been transformed.

Read the whole shebang.

My lede:

A federal jury has found Randeep Mann, MD, guilty on all but one count related to the February 2009 bombing of Arkansas State Medical Board Chair Trent P. Pierce, MD, who nearly died in the blast.

Among other charges, jurors found Dr. Mann, an internist from London, Ark., guilty of using a “weapon of mass destruction” in the bombing that targeted Dr. Pierce. That count alone carries a potential life sentence, said Cherith Beck, public information officer for the Eastern District of Arkansas U.S. Attorney’s Office, which brought the case against Dr. Mann. The verdict was delivered Aug. 9.

The whole shebang.